Role of inhibitors of mammalian target of rapamycin in the treatment of luminal breast cancer.

Ciruelos E, Cortes-Funes H, Ghanem I, Manso L, Arteaga C
Anticancer Drugs. 2013 24 (8): 769-80

PMID: 23838677 · DOI:10.1097/CAD.0b013e328363adc5

MeSH Terms (16)

Androstadienes Animals Antineoplastic Combined Chemotherapy Protocols Aromatase Inhibitors Biomarkers, Tumor Breast Neoplasms Disease-Free Survival Everolimus Female Humans Molecular Targeted Therapy Protein Kinase Inhibitors Signal Transduction Sirolimus TOR Serine-Threonine Kinases Treatment Outcome

Connections (1)

This publication is referenced by other Labnodes entities: